Methods and compositions for freezing and thawing mammalian cells
AssigneeTakeda Pharmaceutical Company Limited
InventorsShuxia Zhou, Lan Cao, Dayong Gao, Qiong Xue, Jiusong Sun, Huang Zhu
Life of this patent
Estimating the term…
Abstract
The present disclosure provides, among other things, a method of cryopreserving and thawing cells that results in the thawed cells having high cellular viability and functionality post-thawing. In some embodiments, a large-scale method of cryopreserving cells is provided, the method comprising: (a) contacting the cells with a cryopreservation medium; (b) cooling the cells to −80° C. at a controlled rate to minimize latent heat of fusion; and (c) storing the cells in liquid nitrogen vapor phase, thereby cryopreserving the immune cells.
Claims6
A cell therapy composition comprising a population of natural killer (NK) cells in a cryopreservation medium comprising sodium chloride, sodium gluconate, sodium acetate trihydrate, potassium chloride, magnesium chloride, trehalose, dimethyl sulfoxide (DMSO) and human serum albumin, wherein the composition is thawed from a cryopreserved state and is characterized by having greater than 90% cell viability.
Dependencies are inferred from the claim text.